However, while pioneering studies had shown that overexpression of wt p53 in cancer null lines induces growth disadvantages [22, 23], it remains unclear whether repairing the same hotspot mutations on their natural locus can exert the same consistent effects across different tumor contexts or if their functional consequences depend on the co-occurring mutational landscape [24–26]. This evidence concerns the gene TP53 and cancer.